1.上海中医药大学附属岳阳中西医结合医院(上海 200437)
2.上海中医药大学(上海 201203)
王立玉,女,硕士,主治医师,主要从事中医药治疗恶性肿瘤的临床与研究工作
龚亚斌,主任医师;E-mail:gongyabin@hotmail.com
谢国群,副主任医师;E-mail:guoqun_shihting@163.com
扫 描 看 全 文
王立玉,陈舲,王芹,等.三棱消瘤合剂联合化疗治疗痰瘀互结型进展期胃癌的临床观察[J].上海中医药杂志,2023,57(4):36-40.
WANG Liyu,CHEN Ling,WANG Qin,et al.Clinical observation on Sanleng Xiaoliu Mixture combined with chemotherapy in treatment of advanced gastric cancer of intermingled phlegm and stasis syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(4):36-40.
王立玉,陈舲,王芹,等.三棱消瘤合剂联合化疗治疗痰瘀互结型进展期胃癌的临床观察[J].上海中医药杂志,2023,57(4):36-40. DOI: 10.16305/j.1007-1334.2023.2209101.
WANG Liyu,CHEN Ling,WANG Qin,et al.Clinical observation on Sanleng Xiaoliu Mixture combined with chemotherapy in treatment of advanced gastric cancer of intermingled phlegm and stasis syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(4):36-40. DOI: 10.16305/j.1007-1334.2023.2209101.
目的,2,观察三棱消瘤合剂联合化疗治疗痰瘀互结型进展期胃癌的临床疗效及安全性。,方法,2,将92例痰瘀互结型进展期胃癌患者根据意愿分为治疗组(,n,=44)和对照组(,n,=48),对照组给予化疗(以氟尿嘧啶为基础方案),治疗组在对照组治疗措施基础上加用三棱消瘤合剂。21 d为1个化疗周期,两组基本疗程均为4个周期,可视情况继续随访治疗至6~8个周期。基本疗程结束后,观察两组中医证候疗效、实体瘤疗效,比较卡氏功能状态(KPS)评分的变化情况;记录化疗周期,比较两组治疗前及治疗第22天、85天时中医证候积分的变化情况,以及基本疗程中的毒性反应发生情况。,结果,2,①治疗组、对照组中医证候总有效率分别为77.3%、50.0%;治疗组中医证候疗效优于对照组(,P,<,0.05)。②两组实体瘤疗效比较,差异无统计学意义(,P,>,0.05)。③治疗组治疗第22天时,胃脘痛、恶心呕吐、纳差、肢体困重积分及中医证候总积分减少(,P,<,0.05),对照组仅中医证候总积分减少(,P,<,0.05)。治疗第85天时组间比较,胃脘痛、恶心呕吐、纳差、肢体困重积分及中医证候总积分差异有统计学意义(,P,<,0.05)。④治疗前后组内比较,治疗组KPS评分升高(,P,<,0.05);组间治疗后比较,治疗组KPS评分高于对照组(,P,<,0.05)。⑤两组完成化疗周期情况比较,差异无统计学意义(,P,>,0.05)。⑥治疗组周围神经毒性反应发生率低于对照组(,P,<,0.05),但两组血液毒性、胃肠道毒性反应发生率比较,差异无统计学意义(,P,>,0.05)。,结论,2,三棱消瘤合剂联合化疗治疗痰瘀互结型进展期胃癌疗效满意,能有效改善患者的中医证候及生活质量,减轻化疗毒性反应。
Objective,2,To observe the clinical efficacy and safety of combining chemotherapy with Sanleng Xiaoliu Mixture in the treatment of advanced gastric cancer of intermingled phlegm and stasis syndrome.,Methods,2,Ninety-two patients with advanced gastric cancer of intermingled phlegm and stasis syndrome were divided into treatment group (,n,=44) and control group (,n,=48) according to their wishes. The control group was given chemotherapy (fluorouracil as the basic regimen), while the treatment group was treated with Sanleng Xiaoliu Mixture in addition to the treatment measures of the control group. A cycle of chemotherapy is 21 days. The basic course of chemotherapy was 4 cycles in both groups, and the follow-up treatment could be continued to 6-8 cycles as appropriate. At the end of the basic course of treatment, syndrome therapeutic evaluation and solid tumor evaluation were conducted, and the changes in Karnofsky Performance Status (KPS) score were compared. The chemotherapy cycles were recorded, and the changes in TCM syndrome scores before treatment and at the 22nd and 85th days of treatment were compared between the two groups, as well as the incidence of toxic reactions during the basic course of treatment.,Results,2,①The total effective rate according to the TCM syndrome therapeutic evaluation was 77.3% in the treatment group and 50.0% in control group; the TCM syndrome therapeutic evaluation in the treatment group was better than that in the control group (,P,<,0.05). ②The difference in the efficacy for solid tumors between the two groups was not statistically significant (,P,>,0.05). ③In the treatment group, the scores of epigastralgia, nausea and vomiting, poor appetite, heavy sensation in the body and limbs and the total TCM syndrome score decreased on day 22 of treatment (,P,<,0.05),while the total TCM syndrome score decreased in the control group(,P,<,0.05).And the differences in the scores of epigastralgia, nausea and vomiting, poor appetite, heavy sensation in the body and limbs and total TCM syndrome score were statistically significant on day 85 of treatment between the two groups(,P,<,0.05). ④After treatment, the KPS score increased in both groups (,P,<,0.05); and the KPS score was higher in the treatment group than that in the control group (,P,<,0.05). ⑤There was no statistically significant difference between the two groups in terms of the completion of chemotherapy cycles (,P,>,0.05). ⑥The incidence of peripheral neurotoxicity in the treatment group was lower than that in the control group (,P,<,0.05), but the difference in the incidence of hematologic toxicity and gastrointestinal toxicity between the two groups was not statistically significant (,P,>,0.05).,Conclusion,2,Sanleng Xiaoliu Mixture with chemotherapy has a good clinical effect on patients with advanced gastric cancer of intermingled phlegm and stasis syndrome as it can significantly improve TCM symptoms and quality of life of patients, and reduce the toxic reaction of chemotherapy.
胃癌三棱消瘤合剂痰瘀互结证中西医结合疗法中医证候临床试验
gastric cancerSanleng Xiaoliu Mixtureintermingled phlegm and stasis syndromeintegrated Chinese and Western medicine therapytraditional Chinese medicine syndromeclinical trial
CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
SUMIYAMA K. Past and current trends in endoscopic diagnosis for early stage gastric cancer in Japan[J]. Gastric Cancer, 2017, 20(Suppl 1): 20-27.
KATAI H, ISHIKAWA T, AKAZAWA K, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007)[J]. Gastric Cancer, 2018, 21(1): 144-154.
MARX V. Tracking metastasis and tricking cancer[J]. Nature, 2013, 494(7435): 133-136.
向亮亮,刘延庆. 中药单体或组分治疗胃癌的实验研究进展[J]. 光明中医,2019, 34(11): 1770-1772.
刘秀彬,王猛,田静,等. 中医中药在胃癌化疗应用的研究进展[J]. 中国中西医结合外科杂志,2019, 25(4): 636-640.
程莉,郭晓冬,马莉,等. 三棱消瘤合剂对进展期胃癌患者疾病无进展生存期及生活质量的影响[J]. 中国中西医结合消化杂志,2018, 26(8): 9-12.
国家卫生健康委员会. 胃癌诊疗规范(2018年版)[J]. 中华消化病与影像杂志,2019, 9(3): 118-144.
陕飞,李子禹,张连海,等. 国际抗癌联盟及美国肿瘤联合会胃癌TNM分期系统(第8版)简介及解读[J]. 中国实用外科杂志,2017, 37(1): 15-17.
上海市卫生局. 上海市中医病证诊疗常规[M]. 2版.上海:上海中医药大学出版社,2003: 130-131.
国家中医药管理局医政司. 中医病证诊断疗效标准[M]. 北京:中国医药科技出版社,2017: 36-37.
孙燕. 临床肿瘤内科手册[M]. 北京:人民卫生出版社,2003: 113.
国家药品监督管理局. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002.
THERASSE P, ARBUCK S G, EISENHAUER E A, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
世界卫生组织.抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J]. 癌症,1992, 11(3): 254.
郑婷婷,焦丽静,阙祖俊,等. 中药诱导肿瘤凋亡相关机制研究进展[J]. 上海中医药杂志,2016, 50(10): 103-109.
GUO H, LUO H, YUAN H, et al. Litchi seed extracts diminish prostate cancer progression via induction of apoptosis and attenuation of EMT through Akt/GSK-3β signaling[J]. Sci Rep, 2017, 7: 41656.
LI C Y, WANG Q, SHEN S, et al. Oridonin inhibits migration, invasion, adhesion and TGF-β1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3β signaling pathway[J]. Oncol Lett, 2018, 15(1): 1362-1372.
钱伯文. 肿瘤辨证施治[M]. 上海:上海科学技术出版社,1980: 36.
齐元富,钱伯文,陈伟,等. 41例胃癌兼挟血瘀证的临床研究[J]. 辽宁中医杂志,1995, 22(2): 70-71.
高玉琼,韩聪,朱国福,等. 钱伯文教授运用莪术治疗恶性肿瘤的经验[J]. 中医药导报,2017, (7): 74-76.
赵倩,程志强. 中西医防治奥沙利铂神经毒性现状[J]. 中华中医药杂志,2018, 33(2): 628-631.
秦宝宁,孙长岗. 益气活血方防治奥沙利铂致大肠癌周围神经毒性疗效观察[J]. 山东中医杂志,2015, 34(3): 176-178.
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构